Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: To investigate the value of prediction of the differentiation level in lung adenocarcinoma based on CT radiomics model.
In this comprehensive review, we delve into the transformative role of artificial intelligence (AI) in refining the application of multi-omics and spatial multi-omics within the realm of diffuse large B-cell lymphoma (DLBCL) research. We scrutinized the current landscape of multi-omics and spatial multi-omics technologies, accentuating their combined potential with AI to provide unparalleled insig...
Purpose: Analyzing noninvasive longitudinal and multimodal data using artificial intelligence could potentially transform immunotherapy for cancer p...
Identifying T-cell receptors (TCRs) that interact with antigenic peptides provides the technical basis for developing vaccines and immunotherapies. ...
The rapid increase in the deployment of Low Earth Orbit (LEO) satellites, catering to diverse applications such as communication, Earth observation,...
In this study, we propose HOPER (HOlistic ProtEin Representation), a novel multimodal learning framework designed to enhance protein function predic...
Cytology slides are essential tools in diagnosing and staging cancer, but their analysis is time-consuming and costly. Foundation models have shown ...
This study leverages the DCTPep database, a comprehensive repository of cancer therapy peptides, to explore the application of machine learning in acc...
Accumulating evidence indicates that long noncoding RNAs (lncRNAs) play important roles in molecular and cellular biology. Although many algorithms ha...
Small sample sizes in biomedical research often led to poor reproducibility and challenges in translating findings into clinical applications. This pr...
Breast cancer is an alarming global health concern, including a vast and varied set of illnesses with different molecular characteristics. The fusion ...
Identification of cancer subtypes is a critical step for developing precision medicine. Most cancer subtyping is based on the analysis of RNA sequenci...
microRNAs (miRNAs) are central post-transcriptional gene expression regulators in healthy and diseased states. Despite decades of effort, deciphering ...
Recent studies suggest cGAS-STING pathway may play a crucial role in the genesis and development of hepatocellular carcinoma (HCC), closely associated...
The identification of cancer driver genes is crucial for understanding the complex processes involved in cancer development, progression, and therapeu...
The burgeoning accumulation of large-scale biomedical data in oncology, alongside significant strides in deep learning (DL) technologies, has establis...
Combination therapies have emerged as a promising approach for treating complex diseases, particularly cancer. However, predicting the efficacy and sa...
The identification of neoantigens is crucial for advancing vaccines, diagnostics, and immunotherapies. Despite this importance, a fundamental question...
Cancer is a highly diverse group of diseases, and each type of cancer can be further divided into various subtypes according to specific characteristi...
Existing algorithms for assessing tumor purity are limited to a single omics data, such as gene expression, somatic copy number variations, somatic mu...